Member Info for Hartlepoolbob

I think that's what I expected. Very relaxed here still..

Time.
https://youtu.be/MQSZR3NSqm8

On with the waiting game peeps.
Stay safe

In difficult times.

Well, a very long wait.
But wonderful news. The journey restarts folks.

Bloody hell, that will keep the tom boy hushed for a while. ;-)
All things in good time.
Nice here init

As normal, a brutally honest and concise response from the boss..
Good here init.
Nap time

Hows aex doin for yer

Bloody heck.. im off to buy a toga daffy

Stick this in a presentation pipe and smoke it :-))

Gerard Brandon, CEO of DeepVerge plc, commented:

 

"Society has depended on anecdotal or theoretical evidence to determine how infectious skin is, as humans touch surfaces and each other. The work in Aberdeen provides factual data and empirical evidence of surface to skin and skin to skin transferability to provide quantifiable infection risks. The body of research, protocols and methods created on Labskin, working with the real virus, offers confirmation and sets standards that allow for testing of our client's anti-viral household, skin and health care products, so that consumers are given scientific evidence behind products claims to kill or address the risk of transmission of the virus.

 

"Labskin is now a proxy skin environment for deep research and testing, beyond Labskin laboratories, with our partners in the universities in Liverpool, UK, Genoa, Italy and Shanghai, China. The extended scientific community can monitor how long the virus remains viable on the skin and provide empirical proof of viral load over the length of time that the virus survives - to show how vulnerable and infectious a human can be in their daily interactions and activities."

 

Somebody's had a full English this morning

Might do it again later if the excitement overwhelms me ;-)

Couldn't resist that... sorry

Julian has more than 30 years of commercial and technical experience in the pharmaceutical industry gained at a number of companies including Chiroscience Plc, Mundipharma International Limited, British Technology Group plc (BTG) and Smith Kline & French (now GlaxoSmithKline plc). Most recently, Julian was co-founder and CEO of Acacia Pharma Group plc (Acacia), raising c.£100m in private and public funding and leading its flotation on Euronext in 2018. Julian resigned from Acacia on 31 July 2019. Prior to Acacia, he was co-founder and Commercial Director of Arakis Limited which was sold to Sosei in 2005 for £107 million. Julian has worked in business development since 1992 and has led multiple business development projects.

 

Julian has a degree in pharmacy and a PhD in pharmaceutics, both from the University of Nottingham.

 

Julian will be appointed as a member of the Nomination & Audit Committees.

 

The Board is also undertaking a search for an additional independent Non-Executive Director with recent and relevant financial experience.

 

 

Dr Chris Blackwell, Executive Chairman, commented:

"It's a pleasure for us to welcome Julian to the Board. Julian's knowledge and experience will be extremely valuable as the Company moves forward with its near-term strategic priorities focussed on business development and licensing opportunities."

Commenting on his appointment, Dr Julian Gilbert said:

"I am delighted to be joining the Board of Nuformix, and look forward to supporting the Company achieve key strategic objectives."

 

 

 

 

 

 

Most bizarre that the sp ever dropped so low anyhow

Do hush up now muggins .

Thats a yes

Halespur, This truly is a most unpleasant and vexing virus. Our eldest daughter, 38 and ward nurse, who got this thing in late March is still poorly and not able to return to her vocation.
Seeing a further specialist on next Monday.
Prayers of condolence and hope for a solution or way forward for all

Strange here, I'm actually beginning to relish the boards despondency .